Effectiveness of Messages to Mobile Phone in Smoke Cessation

October 20, 2015 updated by: Raquel Cobos Campos, Basque Health Service

Evaluation of a Reinforcement Program Using Text Messages Through Mobile Phone in Smoking Cessation Programs in Primary Care

Smoking remains a major risk factor for chronic diseases and is a real problem for health systems. The use of emerging technologies, such as mobile phone , may have a important role in smoking cessation programs through sending reinforcement messages when patients quits smoking.

Main objective: To evaluate the effectiveness of a combined 6 months smoking cessation program including health advice provided by a doctor and sending support messages to mobile phone of patients.

Methods: Study design: Randomized single blind clinical trial. Study population: Patients over 18 who are willing to start a smoking cessation program, who have mobile phone, who are able to receive and send messages, and who have a score greater than 5 or equal to 5 on the Richmond scale.

Sample size: 160 patients per arm to detect a difference in the percentage of smoking cessation than 10% (14.9% vs. 4.9%) between the two groups. Intervention: Experimental group: Health advice and support messages to mobile phone patients.

Control group: Health advice. Assessment of the primary endpoint: At 6 months (positive/negative coximetry test).

Statistical analysis: The analysis of the primary endpoint (positive / negative coximetry test) will be performed using logistic regression.

Study Overview

Study Type

Interventional

Enrollment (Actual)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alava
      • Vitoria-Gasteiz, Alava, Spain, 01009
        • Health centre Lakuabizkarra

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Over 18 years.
  • Current smoker (25): Current smoker is defined as the person who at the time of the study beginning declares that smoked daily or occasionally.
  • Possessing mobile phone.
  • Able to receive and send messages through mobile phone.
  • Score greater than 5 or equal to 5 on the Richmond scale

Exclusion criteria:

  • People with a history of mental and behavioral disorders.
  • Patients with a diagnosis of depression using the depression subscale of Goldberg (two or more positive responses).
  • Patients who with pharmacological therapy for smoking cessation or who require it throughout the study.
  • Pregnant women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: health advice
clinical practice routine
routine clinical practice
Experimental: Quit smoking combined cessation programme
Health advice and support sms messages to patient's mobile phone + clinical routine practice
Support sms messages to patient's mobile phone and health advice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Coximetry test (positive/negative)
Time Frame: at 6 months
at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Continuous abstinence at 6 months: Yes / No
Time Frame: At 6 months
Continuous Abstinence is defined as smoking more than 5 cigarettes since the beginning of the follow-up period self-reported by the patient.
At 6 months
Abstinence point during the first 7 days self-reported by the patient: Yes / No.
Time Frame: at first week
Abstinence is defined as not smoking anything punctual during the last seven days.
at first week
-Prevalence abstinence at the 4th week self-reported by the patient: Yes / No.
Time Frame: At 4th week
At 4th week
-Prevalence abstinence at 12th week self-reported by the patient: Yes / No.
Time Frame: At 12th week
At 12th week
-Outcome of coxymetry test at 12 months of start: Positive / Negative.
Time Frame: at 12 months
Only in patients with a negative result in the 6 months test
at 12 months
Number of messages requested by the patient anxiety.
Time Frame: at 12 months
at 12 months
slip: Yes / No.
Time Frame: at 12 months
Treated as the first use (consumption point) after a period of abstinence
at 12 months
- Relapse: Yes / No.
Time Frame: At 12 months
Relapse is defined to return dependent behavior that had tried to change, recovering or not the baseline levels before treatment.
At 12 months
Number of messages relapse-slip timely requested by the patient.
Time Frame: At 12 months
At 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
other variables
Time Frame: at baseline
Sex (male / female), age (years), number of cigarettes per day before starting program, age of start smoking (years), smoke related pathology (Yes/No), score on the anxiety scale Goldberg, previous attempts to quit smoking (Yes / No if yes, specify number of attempts and reasons for relapse), ), smoking dependence fagerström test score), type of smoker (occasional / daily).
at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

December 7, 2012

First Submitted That Met QC Criteria

December 7, 2012

First Posted (Estimate)

December 10, 2012

Study Record Updates

Last Update Posted (Estimate)

October 21, 2015

Last Update Submitted That Met QC Criteria

October 20, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • TAB-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on health advice

3
Subscribe